IT1250681B - Composizione farmaceutica solida e procedimento per la sua preparazione - Google Patents

Composizione farmaceutica solida e procedimento per la sua preparazione

Info

Publication number
IT1250681B
IT1250681B ITMI912002A ITMI912002A IT1250681B IT 1250681 B IT1250681 B IT 1250681B IT MI912002 A ITMI912002 A IT MI912002A IT MI912002 A ITMI912002 A IT MI912002A IT 1250681 B IT1250681 B IT 1250681B
Authority
IT
Italy
Prior art keywords
preparation
solid pharmaceutical
optionally
nifedipine
procedure
Prior art date
Application number
ITMI912002A
Other languages
English (en)
Italian (it)
Inventor
Attilia Mandi
Margit Csorgo
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ITMI912002A0 publication Critical patent/ITMI912002A0/it
Publication of ITMI912002A1 publication Critical patent/ITMI912002A1/it
Application granted granted Critical
Publication of IT1250681B publication Critical patent/IT1250681B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITMI912002A 1990-07-20 1991-07-19 Composizione farmaceutica solida e procedimento per la sua preparazione IT1250681B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904564A HUT59592A (en) 1990-07-20 1990-07-20 Process for the preparation of solid medical products

Publications (3)

Publication Number Publication Date
ITMI912002A0 ITMI912002A0 (it) 1991-07-19
ITMI912002A1 ITMI912002A1 (it) 1993-01-19
IT1250681B true IT1250681B (it) 1995-04-21

Family

ID=10968329

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912002A IT1250681B (it) 1990-07-20 1991-07-19 Composizione farmaceutica solida e procedimento per la sua preparazione

Country Status (22)

Country Link
JP (1) JPH04253924A (ko)
KR (1) KR920002162A (ko)
BE (1) BE1006829A3 (ko)
CA (1) CA2047482A1 (ko)
CH (1) CH681960A5 (ko)
CY (1) CY1840A (ko)
CZ (1) CZ280064B6 (ko)
DE (1) DE4124081A1 (ko)
DK (1) DK137591A (ko)
ES (1) ES2039177B1 (ko)
FI (1) FI913493A (ko)
FR (1) FR2664814B1 (ko)
GB (1) GB2246072B (ko)
GR (1) GR1002175B (ko)
HU (1) HUT59592A (ko)
IL (1) IL98894A0 (ko)
IT (1) IT1250681B (ko)
NL (1) NL9101268A (ko)
SE (1) SE9102160L (ko)
TW (1) TW203012B (ko)
YU (1) YU47573B (ko)
ZA (1) ZA915677B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411115D0 (en) * 1994-06-03 1994-07-27 Secr Defence Stabilisation of photosensitive material
WO1996033701A1 (en) * 1995-04-24 1996-10-31 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP3549522B1 (ja) * 2003-10-24 2004-08-04 日清ファルマ株式会社 コエンザイムｑ１０含有カプセル剤
WO2010038771A1 (ja) * 2008-09-30 2010-04-08 中外製薬株式会社 光安定化された医薬組成物
CA2968861C (en) 2017-05-30 2022-10-11 University Of Saskatchewan Topical nifedipine formulations and uses thereof
KR200489660Y1 (ko) * 2018-02-09 2019-07-19 김순희 퍼팅연습기

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127448A (en) * 1979-03-23 1980-10-02 Chugai Pharmaceut Co Ltd Gelatin coating
JPS6043046B2 (ja) * 1979-04-24 1985-09-26 パ−ク・デ−ビス・エンド・コンパニ− ゼラチンカプセル
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
JPS61225109A (ja) * 1985-03-29 1986-10-06 Shiseido Co Ltd カラメル含有組成物
DE3526546A1 (de) * 1985-07-25 1987-01-29 Scherer Gmbh R P Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
JPS63215641A (ja) * 1987-03-05 1988-09-08 Toyo Jozo Co Ltd ゼラチン皮膜組成物
JPH01218573A (ja) * 1988-02-25 1989-08-31 Yoshio Tanaka ドナリエラ藻体含有固形状食品の製造法

Also Published As

Publication number Publication date
TW203012B (ko) 1993-04-01
JPH04253924A (ja) 1992-09-09
ES2039177B1 (es) 1994-03-16
YU47573B (sh) 1995-10-03
GR910100319A (el) 1992-08-26
KR920002162A (ko) 1992-02-28
ITMI912002A1 (it) 1993-01-19
CZ280064B6 (cs) 1995-10-18
YU127191A (sh) 1994-05-10
SE9102160L (sv) 1992-01-21
CH681960A5 (ko) 1993-06-30
ZA915677B (en) 1993-03-31
ES2039177A1 (es) 1993-09-01
FI913493A (fi) 1992-01-21
CY1840A (en) 1996-03-08
DK137591D0 (da) 1991-07-19
BE1006829A3 (fr) 1995-01-03
DK137591A (da) 1992-01-21
NL9101268A (nl) 1992-02-17
FR2664814A1 (fr) 1992-01-24
IL98894A0 (en) 1992-07-15
HU904564D0 (en) 1990-12-28
GR1002175B (en) 1996-03-07
GB2246072B (en) 1994-06-15
DE4124081A1 (de) 1992-01-23
FI913493A0 (fi) 1991-07-19
SE9102160D0 (sv) 1991-07-10
HUT59592A (en) 1992-06-29
GB9115693D0 (en) 1991-09-04
FR2664814B1 (fr) 1995-05-24
GB2246072A (en) 1992-01-22
CS222291A3 (en) 1992-02-19
CA2047482A1 (en) 1992-01-21
ITMI912002A0 (it) 1991-07-19

Similar Documents

Publication Publication Date Title
AR033735A1 (es) Compuestos de alfa-aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ATE101516T1 (de) Nifedipin enthaltende oral verabreichbare instant-kapsel.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
IT1250681B (it) Composizione farmaceutica solida e procedimento per la sua preparazione
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
LU91541I2 (fr) latanoprost et ses dérivés pharmaceutiquement acceptables (XALATAN)
FR2314731A1 (fr) Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE843140A (fr) Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
DK442881A (da) Prostaglandinholdigt praeparat
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
DK411388D0 (da) Benzopyranderivater, deres fremstilling og farmaceutiske praeparater deraf
FR2424913A1 (fr) Nouvelles 4-(quinolinylaminobenzoyl) piperazines et composition pharmaceutique les contenant
AR036658A1 (es) Formulacion de dosificacion oral de fundicion instantanea
GB1181673A (en) Derivatives of Xanthen and Thiaxanthen and Preparation Thereof
AR035472A1 (es) Uso de derivados del acido 4-biarilbutirico y 5-biarilpentanoico sustituidos como inhibidores de la metaloproteasa de matriz para el tratamiento de enfermedades respiratorias, compuestos y composiciones que los comprenden
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2063050T3 (es) Derivados de alcoxi-2-oxo-1,2-dihidroquinoxalina substituida en posicion 6.
DE3376198D1 (en) Therapeutic coronary composition in the form of soft gelatine capsules
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
DE69615169D1 (de) N-substituierte azaheterocyclische Carbonsäuren und ihre Alkylester
AR028606A1 (es) Nuevos inhibidores de mmp-2/mmp-9
NO883262L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
ES2160582T3 (es) Capsula dura de ocfosfato de citarabina.
ES2039660T3 (es) Nuevos derivados del (4,5) espiro decano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950728